Atlas Trials

Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma

Clinical trial NCT03119883 · COMPLETED

Trial details

NCT number
NCT03119883
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Monoclonal Gammopathy of Undetermined SignificancePlasma Cell Myeloma
Start date
2017-06-02
Primary completion
2024-06-30
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.